t(9;22)

Oncology
23 drugs in development·6 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(20)
DrugCompany
Bleomycin SulfateAXIM BIOTECHNOLOGIES, INC. (AXIM)
BlinatumomabCrinetics Pharmaceuticals, Inc. (CRNX)
BlinatumomabAXIM BIOTECHNOLOGIES, INC. (AXIM)
CytarabineCrinetics Pharmaceuticals, Inc. (CRNX)
CytarabineAXIM BIOTECHNOLOGIES, INC. (AXIM)
DasatinibAXIM BIOTECHNOLOGIES, INC. (AXIM)
DasatinibCrinetics Pharmaceuticals, Inc. (CRNX)
Daunorubicin HydrochlorideAXIM BIOTECHNOLOGIES, INC. (AXIM)
MesnaCrinetics Pharmaceuticals, Inc. (CRNX)
MesnaAXIM BIOTECHNOLOGIES, INC. (AXIM)
MesnaAssertio Holdings, Inc. (ASRT)
MesnaMerus N.V. (MRUS)
PonatinibENANTA PHARMACEUTICALS INC (ENTA)
Ponatinib HydrochlorideAXIM BIOTECHNOLOGIES, INC. (AXIM)
Ponatinib HydrochlorideCrinetics Pharmaceuticals, Inc. (CRNX)
Procarbazine HydrochlorideAXIM BIOTECHNOLOGIES, INC. (AXIM)
Vinblastine SulfateAXIM BIOTECHNOLOGIES, INC. (AXIM)
VincristineAXIM BIOTECHNOLOGIES, INC. (AXIM)
Vincristine SulfateAXIM BIOTECHNOLOGIES, INC. (AXIM)
Vincristine SulfateCrinetics Pharmaceuticals, Inc. (CRNX)

Compare drugs

Bleomycin Sulfate vs BlinatumomabBleomycin Sulfate vs CytarabineBleomycin Sulfate vs Dasatinib

Frequently asked questions

How many drugs are in development for t(9;22)?

BioSniper tracks 23 drugs in development for t(9;22) across 6 companies.

How many clinical trials target t(9;22)?

There are 1 clinical trial targeting t(9;22) tracked by BioSniper.

Deep-dive into t(9;22)

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    t(9;22) — Drugs in Development & Clinical Trials | BioSniper